CRCbioscreen
next generation colorectal cancer screening

Newsroom



multitarget FIT prospective intervention study in 13,000 participants of the Dutch national colorectal cancer screening program

November 9, 2022, click here

CRCbioscreen strengthens leadership team by appointing Henri Theunissen as CEO

November 1, 2021, click here


CRCbioscreen announces publication of clinical validation data of a multitarget faecal immunochemical test for colorectal cancer screening

July 26, 2021, click here


Health˜Holland has awarded a € 1.003.275 TKI-LSH grant to NKI and CRCbioscreen  for the prospective clinical validation of a novel multitarget FIT in 13000 participants of the Dutch CRC screening program (mtFIT study)

July, 2021, click here


CRCbioscreen raises EUR 875K seed funding for developing a multitarget faecal immunochemical test for improved colorectal cancer screening

March 17, 2021, click here


 
 
 
E-mailen
LinkedIn